Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways
Jan Philipp Bewersdorf, Rory M. Shallis, Amer M. Zeidan
Topics & Concepts
MedicineMyeloid leukemiaClinical trialMyelodysplastic syndromesDiseaseImmunotherapyImmune checkpointMyeloidImmune systemImmunologyInternal medicineBone marrowAcute Myeloid Leukemia ResearchCancer Immunotherapy and BiomarkersMultiple Myeloma Research and Treatments